S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

‘Good Bad’ News For Rambus (RMBS)

Photo of Jon C. Ogg
By Jon C. Ogg Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Rambus Inc. (NASDAQ: RMBS) got some good news on Monday by announcing that the company has signed a patent license agreement with MediaTek Inc. in Taiwan.  What is interesting is that investors are not cheering at all.

The agreement “covers the use of Rambus patented innovations in a broad range of integrated circuit (IC) products offered by MediaTek Inc.”

Also included in the announcement is that these two companies have now settled all outstanding claims against each other.  This settlement includes the resolution of past use of Rambus’ patented innovations.

Terms were not disclosed other than that the term of this patent license agreement is for a period of five years.

Rambus shares are actually down 5.7% at $6.42 and the 52-week trading range is $4.00 to $21.69.

Photo of Jon C. Ogg
About the Author Jon C. Ogg →

Jon Ogg has been a financial news analyst since 1997. Mr. Ogg set up one of the first audio squawk box services for traders called TTN, which he sold in 2003. He has previously worked as a licensed broker to some of the top U.S. and E.U. financial institutions, managed capital, and has raised private capital at the seed and venture stage. He has lived in Copenhagen, Denmark, as well as New York and Chicago, and he now lives in Houston, Texas. Jon received a Bachelor of Business Administration in finance at University of Houston in 1992. a673b.bigscoots-temp.com.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk
David Beren |

52% of Americans Are Building Wealth While Ignoring Their Greatest Risk
3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026
Don Lair |

3 Reasons Retirees Should Not Enroll in Medicare Advantage for 2026

Continue Reading

Jon C. Ogg |

Rambus Scores NVIDIA Licensing Pact (RMBS, NVDA)

Rambus Inc. (NASDAQ: RMBS) has just announced the signing of a patent license agreement with NVIDIA (NASDAQ: NVDA).  The press…
Jon C. Ogg |

NVIDIA Licenses Rambus Patents, More To Come? (NVDA, RMBS)

This is one of those situations you could have likely expected, particularly since the defendant had already said a settlement…
Douglas A. McIntyre |

Rambus Legal Chief Quits… Better or Worse? (RMBS)

Rambus Inc. (NASDAQ:RMBS) announced after the close that its senior legal advisor John Danforth who had been Senior Legal Advisor…
Meet Qualcomm’s Newest Chinese Patent Deal
Chris Lange |

Meet Qualcomm’s Newest Chinese Patent Deal

Qualcomm has announced that it has entered into a new 3G and 4G Chinese patent license agreement with Beijing Tianyu…
Chris Lange |

Qualcomm Gets Chinese Antitrust Risks out of the Way

Qualcomm has announced that it reached a resolution with China’s National Development and Reform Commission regarding its antitrust investigation.
Spherix Soars on New Licensing Agreement
Chris Lange |

Spherix Soars on New Licensing Agreement

Spherix shares more than doubled right out of the gate in Tuesday's trading session, after the company said it entered…
AbbVie and Amgen Reach Global Resolution of Humira
Chris Lange |

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes…
Douglas A. McIntyre |

Apple and HTC Settle Huge Patent Battle

Apple Inc. (NASDAQ: AAPL) seems to be in patent battles with most of the balance of the smartphone and tablet…
Why Alder Biopharma Is Winning Big on Monday
Chris Lange |

Why Alder Biopharma Is Winning Big on Monday

Alder Biopharmaceuticals saw its shares make a solid gain on Monday amid a blizzard of updates from the company.

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618